Viewing nowMyungmoon Alprazolam Tablet 0.25 mg
Alprazolam 0.25mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 201405703 · Approved 2014.12.03 · Insurance code 649806790
Relief of anxiety and panic disorder, and psychosomatic disorders (anxiety, tension, sleep disturbances, etc.)
This medication is used for the treatment of anxiety disorders and for the short-term relief of anxiety symptoms. It is effective for anxiety symptoms accompanying depression, and helps improve anxiety, tension, depression, and sleep disorders caused by psychosomatic disorders. It is also utilized to treat panic disorders. By effectively managing these symptoms, it assists patients in achieving mental stability.
To achieve maximum benefit, the dose should be individualized. The usual daily doses listed below are suitable for most patients, but higher doses may be required. In such cases, increase the dose slowly to avoid adverse effects. The risk of dependence may increase with the dose and duration of administration. Therefore, use the lowest effective dose for the shortest possible duration and frequently reassess the need for continued treatment. ○ Adults 1. The initial dosage of alprazolam is 0.25-0.5㎎ per dose, 3 times daily, with a maximum dose of 4㎎ per day. For elderly patients, patients with hepatic impairment, and debilitated patients, the initial dosage is 0.25㎎ per dose, 2-3 times daily. Reduce the dose if adverse effects occur at the initial dose. 2. Psychosomatic disorders Administer 1.2㎎ of this medicine per day orally in 3 divided doses. If increasing the dose, increase gradually to a maximum of 2.4㎎ per day and administer orally in 3-4 divided doses. For elderly patients, the initial dosage is 0.4㎎ per dose, 1-2 times daily, with a maximum dose of 1.2㎎ per day. 3. Panic disorder The initial dose of this medicine is 0.5㎎. Depending on the patient's response to treatment, increase by no more than 1㎎ at intervals of 3-4 days to an average daily dose of 5-6㎎, administered in 3-4 divided doses. When discontinuing treatment, reduce the dose by no more than 0.5㎎, usually at 3-day intervals; a slower reduction may be required in some cases.
This medication is a benzodiazepine that depresses the central nervous system and has a sedative effect, thus it is used for the treatment of anxiety or panic disorders. This drug can cause severe respiratory depression or coma when used with narcotics, and in severe cases, it may lead to death, so it should only be used at the minimum dose and for the shortest duration needed. This drug carries a risk of abuse and dependence; therefore, during treatment, regular checks of the patient's condition must be performed according to the physician's instructions, and measures should be taken to safely store the medication and properly dispose of any remaining drugs to prevent misuse. Patients with certain conditions, such as acute angle-closure glaucoma, severe myasthenia gravis, severe respiratory failure, severe liver failure, patients with drug or alcohol dependence, and pregnant women in the later stages of pregnancy should not take this medication. Patients with compromised heart, liver, kidney function, or elderly patients, as well as those with organic brain disorders, should use this medication with caution, and dosage adjustments may be necessary. During the course of treatment with this medication, drowsiness or decreased concentration may occur, and driving or operating hazardous machinery should be avoided. For those taking this medication long-term, regular blood tests, liver function tests, and urine tests are recommended, and sudden discontinuation can lead to withdrawal symptoms or seizures, so it should be reduced gradually under the guidance of a physician. This medication may interact with various drugs; thus, patients taking other medications must inform their doctor or pharmacist, especially if they are taking alcohol or central nervous system depressants, as it may pose risks. Women who are pregnant or breastfeeding should consult healthcare professionals before taking this medication as it could affect the fetus or newborn. The safety and efficacy of this drug in pediatrics under 18 years of age have not been established, so it is not administered to children. In case of overdose, severe drowsiness, motor coordination impairment, coma, and respiratory depression may occur, requiring immediate medical treatment, and an antidote may be used if necessary. This medication should be kept out of reach of children and stored in its original packaging instead of being transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not allow light in, and the storage temperature should be maintained between 1 degree to 30 degrees Celsius at room temperature. This helps to maintain the drug's efficacy and safety for a longer period.
White oval tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAlprazolam 0.25mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Alprazolam 0.5mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Alprazolam 0.25mg
Tablet · Prescription medication
Han In Pharmaceutical Co., Ltd.

Alprazolam 0.25mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Alprazolam 0.5mg
Tablet · Prescription medication
Myung In Pharmaceutical Co., Ltd.

Alprazolam 1mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Alprazolam 0.5mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Alprazolam 0.25mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.